Skip to main content
Equibles
VRCA logo

VRCA · Verrica Pharmaceuticals Inc. · Analyst Estimates

Track VRCA — free

Use VRCA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research VRCA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$4.91 -0.04 (-0.81%) At close · Sep 11
Rebalance outlook locked
Going-concern doubt — flagged Aug 6, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Based on our current business plan and current capital resources, combined with the uncertainty regarding the availability of additional funding, we have concluded that there is substantial doubt regarding our ability to continue as a going concern within one year after the date these consolidated financial statements are issued.”
View the 10-Q filed Aug 6, 2026
Market Cap
$84.35M
Shares
17.18M

Analyst Estimates

Compare analyst forecasts for Verrica Pharmaceuticals Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Only independently verified consensus published through the company's investor-relations sources is available.

Consensus not yet available

Only independently verified consensus published through the company's investor-relations sources is available.

Key facts CIK 1660334 CUSIP 92511W207 13F (30d) 17 filings 17 filers Visit website Investor relations